Gastroenterology

Battle of the Biologics in Ulcerative Colitis



<![CDATA[]]>(MedPage Today) — An update of a 2017 network meta-analysis found infliximab (Remicade) to be more effective than other biologics for biologic-naive patients with moderate to severely active ulcerative colitis (UC).
A total of 16 trials published…

Source link

Related posts

Effectiveness of Z-score of log-transformed A Body Shape Index (LBSIZ) in predicting cardiovascular disease in Korea: the Korean Genome and Epidemiology Study

Newsemia

FDA approves ConvertX Biliary Stent System for bile duct obstructions

Newsemia

Is tenofovir associated with lower risk of hepatocellular carcinoma in patients with chronic hepatitis B compared to entecavir?

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World